🇺🇸 FDA

Drug profile · INN

gatifloxacin

GATIFLOXACIN

approved
US status
approved
Patents linked
4
News articles
0

Quick answer

gatifloxacin (GATIFLOXACIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN gatifloxacin
Brand GATIFLOXACIN
Route OPHTHALMIC
Formulation SOLUTION

Related patents

Search patents →

  1. US 7531656

    Synthesis of gatifloxacin

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7411067

    Crystalline forms of gatifloxacin

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7396839

    Crystalline forms of gatifloxacin

    Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7301024

    Crystalline forms of gatifloxacin and processes for preparation

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is gatifloxacin?

gatifloxacin (GATIFLOXACIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for gatifloxacin?

GATIFLOXACIN is a marketed brand name for gatifloxacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of gatifloxacin?

gatifloxacin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.